Frank Takkinen
Stock Analyst at Lake Street
(2.05)
# 2,864
Out of 4,732 analysts
47
Total ratings
38.3%
Success rate
-4.23%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Hold | $5 → $3 | $2.83 | +6.01% | 2 | Jan 15, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $4 → $5 | $4.09 | +22.25% | 2 | Jan 14, 2025 | |
| AVR Anteris Technologies Global | Initiates: Buy | $20 | $5.99 | +233.89% | 1 | Jan 8, 2025 | |
| NSPR InspireMD | Initiates: Buy | $5 | $2.72 | +83.53% | 1 | Dec 11, 2024 | |
| CVRX CVRx, Inc. | Maintains: Buy | $12 → $15 | $17.62 | -14.87% | 6 | Oct 30, 2024 | |
| NOTV Inotiv | Upgrades: Buy | $2 → $4 | $4.27 | -6.32% | 6 | Sep 30, 2024 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $11 → $15 | $15.04 | -0.27% | 3 | Aug 27, 2024 | |
| CLBT Cellebrite DI | Maintains: Buy | $14 → $17 | $22.78 | -25.37% | 2 | Aug 16, 2024 | |
| TELA TELA Bio | Maintains: Buy | $14 → $8 | $2.69 | +197.40% | 2 | Aug 13, 2024 | |
| AORT Artivion | Maintains: Buy | $28 → $30 | $30.72 | -2.34% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $3.20 | +212.50% | 2 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $6.26 | +91.69% | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.41 | +325.53% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.08 | +92.31% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $11.97 | +0.25% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $305 → $350 | $177.68 | +96.98% | 1 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $5 | $1.97 | +154.45% | 3 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $1.39 | +547.48% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.17 | +637.33% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.65 | +1,320.00% | 2 | Jan 18, 2023 |
Sight Sciences
Jan 15, 2025
Maintains: Hold
Price Target: $5 → $3
Current: $2.83
Upside: +6.01%
KORU Medical Systems
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $4.09
Upside: +22.25%
Anteris Technologies Global
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $5.99
Upside: +233.89%
InspireMD
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.72
Upside: +83.53%
CVRx, Inc.
Oct 30, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $17.62
Upside: -14.87%
Inotiv
Sep 30, 2024
Upgrades: Buy
Price Target: $2 → $4
Current: $4.27
Upside: -6.32%
ClearPoint Neuro
Aug 27, 2024
Maintains: Buy
Price Target: $11 → $15
Current: $15.04
Upside: -0.27%
Cellebrite DI
Aug 16, 2024
Maintains: Buy
Price Target: $14 → $17
Current: $22.78
Upside: -25.37%
TELA Bio
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $2.69
Upside: +197.40%
Artivion
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $30.72
Upside: -2.34%
Jun 21, 2024
Maintains: Buy
Price Target: $5 → $10
Current: $3.20
Upside: +212.50%
Jun 4, 2024
Initiates: Buy
Price Target: $12
Current: $6.26
Upside: +91.69%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.41
Upside: +325.53%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.08
Upside: +92.31%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $11.97
Upside: +0.25%
Aug 2, 2023
Maintains: Buy
Price Target: $305 → $350
Current: $177.68
Upside: +96.98%
Jul 19, 2023
Maintains: Buy
Price Target: $2.5 → $5
Current: $1.97
Upside: +154.45%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $1.39
Upside: +547.48%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.17
Upside: +637.33%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.65
Upside: +1,320.00%